Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. 

Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery.
We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications.

Explore our website to learn more www.ncardia.com.


Biotechnology

Life Sciences

Pharmaceutical

Therapeutics

Ncardia

Gustavo Mahler

Shushant Jain

Elodie Noël

Rosa García-Verdugo

Timothy Keefe

Dominique Vanfleteren

Charles Jacques

Stefan Braam

The Scientific Team at Ncardia specializes in advancing drug discovery by leveraging human iPSC technology. This team is responsible for differentiating, manufacturing, and characterizing high-quality iPSC-derived cells and disease models. They facilitate disease modeling and high-throughput screening processes and collaborate closely with biopharmaceutical clients to develop customized iPSC-based solutions that meet specific research and development needs.

Scientific Team

Leadership Team

Directors Team

Scientific Team

About

Team members

Other teams at Ncardia

Leadership Team

Directors Team